Literature DB >> 16289860

TGF-beta and cancer.

Brian Bierie1, Harold L Moses.   

Abstract

TGF-beta signaling regulates tumorigenesis and in human cancer its signaling pathways are often modified during tumor progression. Prior to initiation and early during progression TGF-beta acts upon the epithelium as a tumor suppressor, however at later stages it is often a tumor promoter. Over the years, many studies have focused on the epithelial cell autonomous role for TGF-beta, however, TGF-beta is not strictly limited to this compartment in vivo. Recent studies addressing TGF-beta mediated stromal-epithelial interactions have significantly improved our understanding related to the regulation of cancer. In addition, stromal fibroblast cell autonomous effects have been observed in response to TGF-beta stimulation. According to the current literature and experimental evidence, TGF-beta is a potent ligand that regulates carcinoma initiation, progression and metastasis through a broad and complex spectrum of interdependent interactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16289860     DOI: 10.1016/j.cytogfr.2005.09.006

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  171 in total

1.  TGF-β-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion.

Authors:  Samy Lamouille; Erin Connolly; James W Smyth; Rosemary J Akhurst; Rik Derynck
Journal:  J Cell Sci       Date:  2012-03-07       Impact factor: 5.285

2.  TGF-β and Smad3 modulate PI3K/Akt signaling pathway in vascular smooth muscle cells.

Authors:  Pasithorn A Suwanabol; Stephen M Seedial; Fan Zhang; Xudong Shi; Yi Si; Bo Liu; K Craig Kent
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-23       Impact factor: 4.733

3.  miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells.

Authors:  Charisa L Cottonham; Satoshi Kaneko; Lan Xu
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

Review 4.  Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-β-induced epithelial-mesenchymal transition.

Authors:  Samy Lamouille; Rik Derynck
Journal:  Cells Tissues Organs       Date:  2010-11-02       Impact factor: 2.481

5.  Examination of Smad2 and Smad4 copy-number variations in skin cancers.

Authors:  Yong Shao; Jie Zhang; Richu Zhang; Jun Wan; Wei Zhang; Bo Yu
Journal:  Clin Transl Oncol       Date:  2012-02       Impact factor: 3.405

6.  Serum transforming growth factor-beta1 level reflects disease status in patients with esophageal carcinoma after radiotherapy.

Authors:  Su-Ping Sun; Ye-Ning Jin; Hong-Peng Yang; Yi Wei; Zhao Dong
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

7.  Blood pressure homeostasis is maintained by a P311-TGF-β axis.

Authors:  Kameswara Rao Badri; Ming Yue; Oscar A Carretero; Sree Latha Aramgam; Jun Cao; Stephen Sharkady; Gene H Kim; Gregory A Taylor; Kenneth L Byron; Lucia Schuger
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

Review 8.  Redox-mediated and ionizing-radiation-induced inflammatory mediators in prostate cancer development and treatment.

Authors:  Lu Miao; Aaron K Holley; Yanming Zhao; William H St Clair; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2014-01-22       Impact factor: 8.401

Review 9.  Transforming growth factor beta (TGF-beta) and inflammation in cancer.

Authors:  Brian Bierie; Harold L Moses
Journal:  Cytokine Growth Factor Rev       Date:  2009-12-16       Impact factor: 7.638

10.  Transformation by oncogenic Ras expands the early genomic response to transforming growth factor beta in intestinal epithelial cells.

Authors:  Carl E Allen; Jianguo Du; Bo Jiang; Qin Huang; Adam J Yakovich; John A Barnard
Journal:  Neoplasia       Date:  2008-10       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.